You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

childhood non-Hodgkin lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Childhood Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia Trial in Oslo,

Recruiting
  • Childhood Non-Hodgkin Lymphoma
  • +2 more
  • Goal Management Training (GMT)
  • Brain Health Workshop (BHW)
  • Oslo, Norway
  • +2 more
May 25, 2022

Cognitive Impairment in Young Patients With Cancer Prospectively

Recruiting
  • Chemotherapy-Related Cognitive Impairment
  • +9 more
    • Copenhagen, Denmark
      Rigshospitalet
    Apr 24, 2023

    ADLs at End of Acute Treatment for Childhood Leukemia and

    Enrolling by invitation
    • Childhood Cancer
    • Assessment of the accomplishment regarding Activities of Daily Living at the end of acute treatment
    • Munich, Germany
      Kinderklinik München Schwabing, TUM School of Medicine, Departme
    May 9, 2022

    Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)

    Terminated
    • Lymphoma
    • +15 more
    • Charlottesville, Virginia
      University of Virginia
    Feb 8, 2022

    ALL, Childhood, Lymphoblastic Lymphoma, Childhood, Lymphoblastic Leukemia, Acute, Childhood Trial in Australia, United States

    Recruiting
    • ALL, Childhood
    • +2 more
    • Los Angeles, California
    • +17 more
    Aug 11, 2022

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +35 more
    • Birmingham, Alabama
    • +113 more
    Jun 28, 2022

    Childhood Cancer Trial in Munich (Exercise)

    Completed
    • Childhood Cancer
    • Exercise
    • Munich, Bavaria, Germany
      Kinderklinik München Schwabing TUM School of Medicine, Departmen
    May 26, 2021

    Social and Genetic Factors on Outcomes in Adolescent and Young

    Not yet recruiting
    • Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma
    • Biospecimen Collection
    • +2 more
    • (no location specified)
    Aug 18, 2023

    Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)

    Not yet recruiting
    • Classical Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma
    • GEN3017
    • (no location specified)
    Aug 25, 2023

    B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

    Recruiting
    • B-Cell Non Hodgkin Lymphoma
    • B-Cell Acute Lymphoblastic Leukemia
    • anti-CD19 CAR T-cells
    • Hanoi, Vietnam
      Vinmec Research Institute of Stem Cell and Gene Technology
    Sep 5, 2023

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    B-cell Non-Hodgkin's Lymphoma Trial (SHR-A1912; R-Chemo)

    Not yet recruiting
    • B-cell Non-Hodgkin's Lymphoma
    • SHR-A1912; R-Chemo
    • (no location specified)
    Oct 23, 2023

    Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • +9 more
    • CD79b-19 CAR T cells
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 6, 2023

    Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)

    Not yet recruiting
    • Non-hodgkin's Lymphoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Sep 27, 2023

    Familial Investigations of Childhood Cancer Predisposition

    Recruiting
    • Acute Leukemia
    • +45 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      May 11, 2022

      Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +2 more
      • Low-field magnetic resonance imaging
      • +3 more
      • Erlangen, Bavaria, Germany
        Department of Pediatrics and Adolescent Medicine
      Oct 23, 2023

      Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

      Not yet recruiting
      • Relapsed/Refractory Non-Hodgkin Lymphoma
      • Duarte, California
      • +1 more
      Oct 13, 2023

      Non-hodgkin Lymphoma Trial (CD38-SADA:177Lu-DOTA Complex)

      Not yet recruiting
      • Non-hodgkin Lymphoma
      • CD38-SADA:177Lu-DOTA Complex
      • (no location specified)
      Aug 15, 2023

      Non Hodgkin Lymphoma Trial in New York, Clayton, Frankston (IPH6501)

      Not yet recruiting
      • Non Hodgkin Lymphoma
      • New York, New York
      • +2 more
      Oct 12, 2023

      B-cell Non-Hodgkin's Lymphoma Trial (IMM0306, Lenalidomide capsule)

      Not yet recruiting
      • B-cell Non-Hodgkin's Lymphoma
      • (no location specified)
      Mar 6, 2023

      Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

      Recruiting
      • Non-Hodgkin Lymphoma
      • Hodgkin Lymphoma
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Jan 25, 2023

      Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma

      Recruiting
      • Lymphoma
      • +2 more
      • Shanghai, Shanghai, China
      • +2 more
      May 9, 2023

      Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

      Not yet recruiting
      • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
      • (no location specified)
      Mar 23, 2023

      Advanced Solid Tumors, Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Multiple Myeloma Trial in Gyeonggi-do,

      Recruiting
      • Advanced Solid Tumors
      • +2 more
      • GIC-102 (Allogeneic NK cells)
      • Gyeonggi-do, Korea, Republic of
      • +3 more
      May 18, 2023

      Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

      Not yet recruiting
      • Lymphoma, T-Cell, Cutaneous
      • +5 more
      • (no location specified)
      Nov 2, 2023